Shares of Idera Pharmaceuticals (IDRA) soared trading on Monday after the FDA granted orphan designation to the company’s treatment of Waldenstrom’s macroglobulinemia. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) belongs to Healthcare sector. Its weekly performance is 9.22%. On last trading day company shares ended up $4.50. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) distance from 50-day simple moving average (SMA50) is 47.54%.
Comcast (NASDAQ:CMCSA) SVP Arthur R. Block sold 7,407 shares of the stock on the open market in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $55.21, for a total value of $408,940.47. Comcast Corporation (NASDAQ:CMCSA) shares increased 0.83% in last trading session and ended the day at $58.88. CMCSA Gross Margin is 69.40% and its return on assets is 5.30%. Comcast Corporation (NASDAQ:CMCSA) quarterly performance is 8.71%.
NCI, Inc. (NASDAQ:NCIT) said Monday that it has agreed to buy Computech, Inc., which is engaged in agile and lean application software development and IT operations and maintenance, for about $56 million in cash, subject to certain working capital and other adjustments. NCI, Inc. (NASDAQ:NCIT) belongs to Technology sector. Its net profit margin is 2.90% and weekly performance is 1.57%. On last trading day company shares ended up $10.36. NCI, Inc. (NASDAQ:NCIT) distance from 50-day simple moving average (SMA50) is -4.74%.
On Dec 16, PNM Resources, Inc. (NYSE:PNM) announced its ongoing earnings guidance for 2015 and affirmed its consolidated ongoing earnings guidance for 2014. PNM Resources reaffirmed its consolidated ongoing earnings guidance for 2014 in the range of $1.44-$1.51 per diluted share. PNM Resources, Inc. (NYSE:PNM) ended the last trading day at $31.39. Company weekly volatility is calculated as 2.00% and price to cash ratio as 88.04. PNM Resources, Inc. (NYSE:PNM) showed a weekly performance of 7.50%.
Shares of PacWest Bancorp (NASDAQ:PACW) have earned a consensus recommendation of “Buy” from the eight analysts that are covering the stock, American Banking & Market News reports. Two research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. PacWest Bancorp (NASDAQ:PACW) shares increased 1.01% in last trading session and ended the day at $46.20. PACW return on assets is 1.10%. PacWest Bancorp (NASDAQ:PACW) quarterly performance is 12.74%.